rofecoxib has been researched along with Mouth Ulcer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib is an inhibitor of the enzyme cyclo-oxygenase 2 (COX-2) used as an analgesic and anti-inflammatory agent especially in rheumatoid arthritis and osteoarthritis." | 1.32 | Adverse oral reactions associated with the COX-2 inhibitor rofecoxib. ( Bagán, JV; Scully, C; Thongprasom, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagán, JV | 1 |
| Thongprasom, K | 1 |
| Scully, C | 1 |
1 other study available for rofecoxib and Mouth Ulcer
| Article | Year |
|---|---|
Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Female; | 2004 |